Popowski Katrin, Eloranta Jyrki J, Saborowski Michael, Fried Michael, Meier Peter J, Kullak-Ublick Gerd A
Laboratory of Molecular Gastroenterology and Hepatology, University Hospital, Zurich, Switzerland.
Mol Pharmacol. 2005 May;67(5):1629-38. doi: 10.1124/mol.104.010223. Epub 2005 Feb 3.
The human organic anion transporter 2 (hOAT2, SLC22A7) mediates the sodium-independent uptake of numerous drugs, including cephalosporins, salicylates, dicarboxylates, and prostaglandins, and is mainly expressed in hepatocytes. Because the regulation of hOAT2 expression is poorly understood, we characterized cis-acting elements in the 5'-flanking region that regulate hOAT2 transcription. A consensus binding motif for the hepatocyte nuclear factor-4 alpha (HNF-4 alpha), arranged as a direct repeat (DR)-1, is located at nucleotides -329/-317 relative to the transcription initiation site. This element specifically binds HNF-4 alpha in electrophoretic mobility shift assays. A luciferase-linked hOAT2 promoter fragment containing the HNF-4 alpha binding site was transactivated upon cotransfection of an HNF-4 alpha expression vector in Huh7 cells, whereas site-directed mutagenesis of the DR-1 element abolished activation by HNF-4 alpha. Short interfering RNAs inhibiting endogenous HNF-4 alpha expression markedly reduced endogenous expression of hOAT2 in Huh7 cells. Because HNF-4 alpha is a known target for bile acid-mediated repression of gene transcription, we studied whether chenodeoxycholic acid (CDCA) suppresses hOAT2 gene expression by inhibiting HNF-4 alpha-mediated transactivation. Treatment of Huh7 cells with CDCA or the synthetic farnesoid X receptor (FXR) agonist GW4064 decreased mRNA and protein levels and also nuclear binding activity of HNF-4 alpha. The FXR-inducible transcriptional repressor small heterodimer partner inhibited transactivation of hOAT2 promoter constructs and of endogenous hOAT2 expression by HNF-4 alpha. We conclude that the hOAT2 gene is critically dependent on HNF-4 alpha and that bile acids repress the hOAT2 gene by inhibiting HNF-4 alpha. Hepatic uptake of hOAT2 substrates may thus be decreased in disease conditions associated with elevated intracellular levels of bile acids.
人类有机阴离子转运体2(hOAT2,SLC22A7)介导多种药物的非钠依赖性摄取,这些药物包括头孢菌素、水杨酸盐、二羧酸盐和前列腺素,并且主要在肝细胞中表达。由于对hOAT2表达的调控了解甚少,我们对5'-侧翼区域中调控hOAT2转录的顺式作用元件进行了表征。肝细胞核因子-4α(HNF-4α)的共有结合基序,排列为直接重复序列(DR)-1,位于相对于转录起始位点的核苷酸-329/-317处。在电泳迁移率变动分析中,该元件特异性结合HNF-4α。在Huh7细胞中共转染HNF-4α表达载体后,包含HNF-4α结合位点的荧光素酶连接的hOAT2启动子片段被反式激活,而DR-1元件的定点诱变消除了HNF-4α的激活作用。抑制内源性HNF-4α表达的小干扰RNA显著降低了Huh7细胞中hOAT2的内源性表达。由于HNF-4α是胆汁酸介导基因转录抑制的已知靶点,我们研究了鹅去氧胆酸(CDCA)是否通过抑制HNF-4α介导的反式激活来抑制hOAT2基因表达。用CDCA或合成法尼醇X受体(FXR)激动剂GW4064处理Huh7细胞,可降低mRNA和蛋白质水平以及HNF-4α的核结合活性。FXR诱导型转录抑制因子小异源二聚体伴侣抑制HNF-4α对hOAT2启动子构建体和内源性hOAT2表达的反式激活。我们得出结论,hOAT2基因严重依赖HNF-4α,并且胆汁酸通过抑制HNF-4α来抑制hOAT2基因。因此,在与细胞内胆汁酸水平升高相关的疾病状态下,hOAT2底物的肝摄取可能会降低。